Although E-cadherin is well recognised as a broad-acting tumour suppressor in hereditary and sporadic gastric carcinomas, we are still far from understanding the molecular events underlying the onset of cadherin-dependent cancer in the gastric epithelium. Here, CDH17 is linked to gastric carcinoma.